{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360866922334548736.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/s0022-3565(24)37347-1"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022356524373471?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0022356524373471?httpAccept=text/plain"}}],"dc:title":[{"@value":"Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380866922334548741","@type":"Researcher","foaf:name":[{"@value":"Mong-Heng Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866922334548739","@type":"Researcher","foaf:name":[{"@value":"Elimor Brand-Schieber"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866922334548738","@type":"Researcher","foaf:name":[{"@value":"Barbara A. Zand"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866922334548737","@type":"Researcher","foaf:name":[{"@value":"Xuandai Nguyen"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866922334548736","@type":"Researcher","foaf:name":[{"@value":"John R. Falck"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866922334548740","@type":"Researcher","foaf:name":[{"@value":"Narayanan Balu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380866922334548742","@type":"Researcher","foaf:name":[{"@value":"Michal Laniado Schwartzman"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00223565"}],"prism:publicationName":[{"@value":"The Journal of Pharmacology and Experimental Therapeutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1998-03","prism:volume":"284","prism:number":"3","prism:startingPage":"966","prism:endingPage":"973"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0022356524373471?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0022356524373471?httpAccept=text/plain"}],"createdAt":"2025-01-04","modifiedAt":"2025-02-20","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680158304640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Predicting Oxidation Sites with Order of Occurrence among Multiple Sites for CYP4A-mediated Reactions"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/s0022-3565(24)37347-1"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-11-rg-004_references_DOI_9ozGIKjkPmxsrYEnNeQadAsdQEF"}]}